Step forward in solidarity for International Women's Day (IWD) 2025 on March 8 to help #AccelerateAction.
The Aikenhead Centre for Medical Discovery (ACMD) is not just a new building on St Vincent’s campus, Fitzroy – it’s the product of two decades of vision, persistence, and deep collaboration across sectors.
A spirit of camaraderie and purpose filled the air as supporters, sponsors, and scientists came together for the 16th SVI Golf Day at Kew Golf Club – an event that raised more than $110,000 for the cutting-edge research taking place at SVI.
A spirit of camaraderie and purpose filled the air as supporters, sponsors, and scientists came together for the 16th SVI Golf Day at Kew Golf Club – an event that raised more than $110,000 for the cutting-edge research taking place at SVI.
SVI is proud to honour the life and legacy of Professor Helen Thomas, whose pioneering research in type 1 diabetes transformed the field.
A new national research program is working to deliver the first targeted treatments for a group of aggressive, treatment-resistant cancers.
When Oona lines up for the Sydney Marathon this August, every one of the 42 kilometres she runs will be for her nephew Noah and every other child living with Fanconi anaemia.
Dr Kylie Jevon has been awarded the 2026 Helen Thomas Early Career Fellowship in Type 1 Diabetes, recognising the outstanding potential of her research investigating a novel immunotherapy approach, and honouring the enduring legacy of Professor Helen Thomas.
SVI today welcomes Professor Fabienne Mackay as our new Director, only the fifth person to lead the Institute in its 68-year history.
SVI researchers have been awarded US$250,000 from the Friedreich’s Ataxia Research Alliance (FARA) to investigate new ways to understand and treat heart disease in people with Friedreich ataxia.
A daily tablet that protects insulin production in people newly diagnosed with type 1 diabetes is likely to work best taken continuously rather than as a short course, new SVI research shows.
SVI researchers have identified a promising new approach that could one day help protect the heart from the damaging side effects of some cancer treatments.
SVI researchers have been awarded a grant from the US-based Bloom Syndrome Association to investigate a gene editing approach that could one day lead to better treatments for the condition.
Professor Louise Purton has been appointed President of the International Society for Experimental Hematology (ISEH), the world's largest society devoted to experimental haematology.
Dr Jarmon Lees, Head of SVI’s Cardiometabolic Disease Lab, has been named a recipient of the 2026 Victorian Young Tall Poppy Science Award.
Dr David De George has been awarded the 2026 TJ Martin Medal for outstanding PhD research into type 1 diabetes, presented at a ceremony during St Vincent's Melbourne Research Week.
A new international study, led by Associate Professor Irene Gallego Romero, has revealed gaps in how human diversity is represented and reported in some of the world's largest public genomics databases.
Join SVI this National Science Week for Decoding the future of medical research, a free public event exploring how artificial intelligence is reshaping the future of healthcare.
Associate Professor Stuart Mannering, Head of Human Immunology, and his research team, have been awarded almost $1 million through the Medical Research Future Fund (MRFF) to develop a new blood test that could transform how type 1 diabetes is detected and treated.
SVI researchers have uncovered a previously unknown process that helps cells repair damage in one of the most active and vulnerable parts of their DNA.